Variation in methods of predicting adult height for children with idiopathic short stature

Pediatrics

Volumn 126, Issue 5, 2010, Pages 938-944

  Topor, Lisa Swartz ^a   Feldman, Henry A ^a,b   Bauchner, Howard ^c   Cohen, Laurie E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Growth hormone; Height prediction; Idiopathic short stature

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BAYLEY PINNEAU METHOD; BODY HEIGHT; BODY WEIGHT; BONE AGE; CHILD; CLINICAL ASSESSMENT TOOL; FEMALE; GROUPS BY AGE; HORMONAL THERAPY; HUMAN; IDIOPATHIC SHORT STATURE; KHAMIS ROCHE METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; ROCHE WAINER THISSEN METHOD; SCHOOL CHILD; SHORT STATURE; SIMULATION;

ADOLESCENT; ADULT; AGE DETERMINATION BY SKELETON; ALGORITHMS; BODY HEIGHT; BODY WEIGHT; CHILD; DWARFISM; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; RECOMBINANT PROTEINS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 78049439308     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-3649     Document Type: Article

References (31)

1. Food and Drug Administration. FDA approves Humatrope for short stature. Available at: www.fda.gov/bbs/topics/ANSWERS/ 2003/ANS01242.html. Accessed October 31, 2005
2. Cuttler L, Silvers JB. Growth hormone treatment for idiopathic short stature: implications for practice and policy. Arch Pediatr Adolesc Med. 2004;158(2):108-110 (Pubitemid 38173961)
3. Leschek EW, Rose SR, Yanovski JA, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, doubleblind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(7):3140-3148
4. Wit JM, Rekers-Mombarg LT, Cutler GB, et al. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr. 2005;146(1):45-53 (Pubitemid 40091730)
5. Bryant J, Baxter L, Cave CB, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database Syst Rev. 2007;(3): CD004440
6. Lee JM, Davis MM, Clark SJ, Hofer TP, Kemper AR. Estimated cost-effectiveness of growth hormone therapy for idiopathic short stature. Arch Pediatr Adolesc Med. 2006;160(3):263-269 (Pubitemid 43374359)
7. Von Fange T, McDiarmid T, Mackler L, Zolotor A. Clinical inquiries: can recombinant growth hormone effectively treat idiopathic short stature? J Fam Pract. 2008;57(9): 611-612
8. Tzeel A, Fine MJ. Plan and pharmacy perspectives: growth hormone therapy, formulary, and benefit authorization. Manag Care. 2009;18(8 suppl 6):17-19
9. LaFranchi S, Hanna CE, Mandel SH. Constitutional delay of growth: expected versus final adult height. Pediatrics. 1991;87(1):82-87
10. Hardin DS, Woo J, Butsch R, Huett B. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists. Clin Endocrinol (Oxf). 2007;66(1):85-94 (Pubitemid 44952499)
11. Grimberg A, Kutikov JK, Cucchiara AJ. Sex differences in patients referred for evaluation of poor growth. J Pediatr. 2005;146(2): 212-216 (Pubitemid 40202811)
12. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109(1):45-60
13. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40(4):423-441
14. Roche AF, Wainer H, Thissen D. The RWT method for the prediction of adult stature. Pediatrics. 1975;56(6):1027-1033
15. Khamis HJ, Roche AF. Predicting adult stature without using skeletal age: the Khamis- Roche method. Pediatrics. 1994;94(4): 504-507
16. Chmura Kraemer H, Periyakoil VS, Noda A. κ coefficients in medical research. Stat Med. 2002;21(14):2109-2129
17. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: Wiley; 1981
18. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH. Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab. 1998;83(4): 1075-1079 (Pubitemid 28496371)
19. Hindmarsh PC, Brook CG. Final height of short normal children treated with growth hormone. Lancet. 1996;348(9019):13-16 (Pubitemid 26237239)
20. Midyett LK, Rogol AD, Van Meter QL, Frane J, Bright GM; MS301 Study Group. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2010;95(2):611-619
21. Kamp GA, Mul D, Waelkens JJ, et al. A randomized controlled trial of three years growth hormone and gonadotropinreleasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab. 2001;86(7):2969-2975 (Pubitemid 32673450)
22. Cohen P, Rogol AD, Deal CL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93(11):4210-4217 (Pubitemid 352806728)
23. Maes M, Vandeweghe M, Du Caju M, Ernould C, Bourguignon JP, Massa G. A valuable improvement of adult height prediction methods in short normal children. Horm Res. 1997;48(4):184-190 (Pubitemid 27403987)
24. Roemmich JN, Blizzard RM, Peddada SD, et al. Longitudinal assessment of hormonal and physical alterations during normal puberty in boys, part IV: predictions of adult height by the Bayley-Pinneau, Roche- Wainer-Thissen, and Tanner-Whitehouse methods compared. Am J Hum Biol. 1997; 9(3):371-380
25. Sperlich M, Butenandt O, Schwarz HP. Final height and predicted height in boys with untreated constitutional growth delay. Eur J Pediatr. 1995;154(8):627-632
26. Joss EE, Temperli R, Mullis PE. Adult height in constitutionally tall stature: accuracy of five different height prediction methods. Arch Dis Child. 1992;67(11):1357-1362
27. Bull RK, Edwards PD, Kemp PM, Fry S, Hughes IA. Bone age assessment: a large scale comparison of the Greulich and Pyle, and Tanner and Whitehouse (TW2) methods. Arch Dis Child. 1999;81(2):172-173 (Pubitemid 29350000)
28. Thodberg HH, Jenni OG, Caflisch J, Ranke MB, Martin DD. Prediction of adult height based on automated determination of bone age. J Clin Endocrinol Metab. 2009;94(12): 4868-4874
29. Greulich WW, Pyle SI, Brush Foundation Cleveland. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press; 1950
30. Loder RT, Estle DT, Morrison K, et al. Applicability of the Greulich and Pyle skeletal age standards to black and white children of today. Am J Dis Child. 1993;147(12):1329-1333 (Pubitemid 23359955)
31. Zhang A, Sayre JW, Vachon L, Liu BJ, Huang HK. Racial differences in growth patterns of children assessed on the basis of bone age. Radiology. 2009;250(1):228-235